Table 2 Human studies investigating the role of vagal nerve blockade (VBLOC) in weight loss, glucose control and caloric intake
& Gordon, J
In one trial, the dose increased every four weeks , building up to a maintenance dose of 12 mg : Week 14: 2 mg Week 58: 4 mg Week 912: 8 mg Week 13+ (maintenance): 12 mg However, this may change depending on the final trial results
This medication mimics the action of endogenous GLP-1, a hormone released from the intestine in response to food intake
Moreover, individuals who are malnourished, have cancer, are elderly, pregnant, or are alcoholics are also at higher risk in suffering the lack of vitamin B12
Promotes emotional stability